Literature DB >> 21200862

4-[4-(4-Fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide-4-[3-(4-fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide (0.6/0.4).

Simona Margutti, Dieter Schollmeyer, Stefan Laufer.   

Abstract

The crystal structure of the title compound, C(16)H(16)FN(2)O(2) (+)·I(-), was determined as part of a study of the biological activity of isoxazolone derivatives as p38 mitogen-activated protein kinase (MAPK) inhibitors. The X-ray crystal structure of 4-[4-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide showed the presence of the regioisomer 4-[3-(4-fluoro-phenyl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide. The synthesis of the former compound was achieved by reacting 4-(4-fluoro-phenyl)-3-(4-pyridyl)isoxazol-5(2H)-one after treatment with Et(3)N in dimethyl-formamide, with iodo-methane. The unexpected formation of the regioisomer could be explained by a rearrangement occurring via aziridine of the isoxazolone compound. The regioisomers have site occupancies of 0.632 (4)/0.368 (4). The two six members rings make a dihedral angle of 66.8 (2)°.

Entities:  

Year:  2007        PMID: 21200862      PMCID: PMC2915348          DOI: 10.1107/S1600536807055985

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background on the pharmaceutical applications of isoxazolones, see: Laughlin et al. (2005 ▶); Clark et al. (2002 ▶); Wang et al. (1998 ▶); Foster et al. (2000 ▶); Adams et al. (1998 ▶); Laufer & Wagner (2002 ▶); de Laszlo et al. (1998 ▶); Laufer et al. (2005 ▶, 2006 ▶); Revesz et al. (2000 ▶); Ohkawa et al. (2001 ▶). The aziridine rearrangement of isoxazolones was described by Nishiwaki & Saito (1971 ▶) and Sauers (1990 ▶).

Experimental

Crystal data

C15H12FN2O2 +·I− M = 398.17 Monoclinic, a = 10.2804 (4) Å b = 20.5895 (9) Å c = 7.4907 (3) Å β = 96.8828 (14)° V = 1574.12 (11) Å3 Z = 4 Mo Kα radiation μ = 2.05 mm−1 T = 193 (2) K 0.52 × 0.20 × 0.08 mm

Data collection

Bruker SMART APEXII CCD diffractometer Absorption correction: multi-scan (APEX2; Bruker, 2006 ▶) T min = 0.415, T max = 0.853 27681 measured reflections 3897 independent reflections 3369 reflections with I > 2σ(I) R int = 0.126

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.115 S = 1.07 3897 reflections 188 parameters H-atom parameters constrained Δρmax = 1.60 e Å−3 Δρmin = −0.51 e Å−3 Data collection: APEX2 (Bruker, 2006 ▶); cell refinement: APEX2; data reduction: APEX2; program(s) used to solve structure: SIR92 (Altomare et al., 1994 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997 ▶); molecular graphics: ORTEP (Johnson, 1968 ▶) and PLATON (Spek, 2003 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536807055985/bt2577sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536807055985/bt2577Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C15H12FN2O2+·IF000 = 776
Mr = 398.17Dx = 1.680 Mg m3
Monoclinic, P21/cMo Kα radiation λ = 0.71069 Å
Hall symbol: -P 2ybcCell parameters from 6868 reflections
a = 10.2804 (4) Åθ = 2.7–28.3º
b = 20.5895 (9) ŵ = 2.05 mm1
c = 7.4907 (3) ÅT = 193 (2) K
β = 96.8828 (14)ºBlock, brown
V = 1574.12 (11) Å30.52 × 0.20 × 0.08 mm
Z = 4
Bruker APEXII CCD diffractometer3369 reflections with I > 2σ(I)
Monochromator: graphiteRint = 0.126
T = 193(2) Kθmax = 28.4º
CCD scanθmin = 2.0º
Absorption correction: multi-scan(APEX2; Bruker, 2006)h = −13→13
Tmin = 0.415, Tmax = 0.853k = −27→27
27681 measured reflectionsl = −9→9
3897 independent reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.040H-atom parameters constrained
wR(F2) = 0.115  w = 1/[σ2(Fo2) + (0.0617P)2 + 2.8681P] where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max = 0.001
3897 reflectionsΔρmax = 1.60 e Å3
188 parametersΔρmin = −0.51 e Å3
Primary atom site location: structure-invariant direct methodsExtinction correction: none
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
F1A1.0107 (3)0.20467 (16)1.6192 (4)0.0292 (4)0.632 (4)
F1B0.3217 (5)0.1835 (3)0.8219 (7)0.0292 (4)0.368 (4)
C10.9450 (4)0.08719 (19)0.9398 (5)0.0327 (7)
C20.8322 (4)0.07466 (19)0.8261 (5)0.0333 (7)
N30.8565 (3)0.0373 (2)0.6894 (5)0.0458 (9)
O40.9887 (3)0.02271 (16)0.7079 (4)0.0439 (7)
C51.0475 (4)0.0546 (2)0.8619 (6)0.0384 (8)
C60.7766 (4)0.0089 (2)0.5375 (6)0.0408 (9)
H6A0.8320−0.01680.46670.061*
H6B0.73370.04350.46230.061*
H6C0.7100−0.01910.58060.061*
O71.1646 (3)0.04901 (16)0.8994 (5)0.0489 (8)
C80.9607 (4)0.12052 (18)1.1149 (5)0.0332 (8)
C90.8538 (4)0.1315 (2)1.2097 (6)0.0359 (8)
H90.76870.11871.15840.043*
C100.8700 (4)0.1609 (2)1.3781 (6)0.0399 (9)
H100.79690.16911.44120.048*
C11A0.9937 (5)0.1776 (2)1.4501 (6)0.0462 (9)0.632 (4)
N11B0.9937 (5)0.1776 (2)1.4501 (6)0.0462 (9)0.368 (4)
H11B1.00460.19581.55710.055*0.368 (4)
C121.1020 (4)0.1672 (2)1.3625 (6)0.0458 (10)
H121.18680.17951.41620.055*
C131.0846 (4)0.1386 (2)1.1952 (6)0.0413 (9)
H131.15860.13101.13330.050*
C150.6988 (4)0.10094 (19)0.8287 (5)0.0312 (7)
C160.5906 (4)0.06123 (19)0.8311 (5)0.0336 (7)
H160.60030.01530.83480.040*
C170.4681 (4)0.0892 (2)0.8282 (5)0.0352 (8)
H170.39320.06230.83080.042*
N18A0.4542 (3)0.15364 (17)0.8217 (4)0.0292 (4)0.632 (4)
H18A0.37530.17050.81930.035*0.632 (4)
C18B0.4542 (3)0.15364 (17)0.8217 (4)0.0292 (4)0.368 (4)
C190.5569 (4)0.1931 (2)0.8188 (6)0.0364 (8)
H190.54410.23880.81560.044*
C200.6822 (4)0.16808 (19)0.8204 (5)0.0354 (8)
H200.75520.19610.81600.042*
I10.47781 (2)0.126317 (12)0.31747 (3)0.03385 (11)
U11U22U33U12U13U23
F1A0.0284 (10)0.0371 (11)0.0211 (9)0.0016 (8)−0.0013 (7)−0.0038 (8)
F1B0.0284 (10)0.0371 (11)0.0211 (9)0.0016 (8)−0.0013 (7)−0.0038 (8)
C10.0289 (17)0.0352 (19)0.0353 (18)0.0032 (14)0.0087 (14)0.0040 (14)
C20.0329 (18)0.0339 (19)0.0339 (18)0.0020 (14)0.0065 (14)0.0026 (14)
N30.0312 (17)0.061 (2)0.045 (2)0.0125 (16)0.0037 (15)−0.0117 (17)
O40.0336 (14)0.0525 (18)0.0474 (17)0.0086 (13)0.0122 (12)−0.0064 (14)
C50.0325 (19)0.038 (2)0.045 (2)0.0013 (16)0.0092 (16)0.0042 (16)
C60.040 (2)0.042 (2)0.042 (2)0.0019 (17)0.0108 (17)−0.0077 (17)
O70.0292 (14)0.0528 (18)0.067 (2)0.0032 (12)0.0151 (14)0.0009 (16)
C80.0303 (18)0.0346 (19)0.0349 (19)−0.0006 (14)0.0047 (15)0.0048 (14)
C90.0286 (17)0.046 (2)0.0336 (19)0.0007 (15)0.0036 (15)0.0009 (15)
C100.037 (2)0.048 (2)0.035 (2)0.0035 (17)0.0049 (16)−0.0002 (17)
C11A0.055 (2)0.043 (2)0.039 (2)−0.0025 (18)−0.0002 (18)0.0000 (17)
N11B0.055 (2)0.043 (2)0.039 (2)−0.0025 (18)−0.0002 (18)0.0000 (17)
C120.037 (2)0.050 (3)0.048 (2)−0.0095 (18)−0.0029 (18)0.0029 (19)
C130.0297 (19)0.048 (2)0.047 (2)−0.0043 (16)0.0057 (17)0.0058 (18)
C150.0331 (17)0.0352 (18)0.0257 (16)0.0025 (14)0.0045 (13)−0.0009 (14)
C160.0372 (19)0.0332 (18)0.0313 (17)−0.0009 (15)0.0079 (15)−0.0007 (14)
C170.0360 (19)0.038 (2)0.0323 (18)−0.0024 (15)0.0063 (15)−0.0016 (14)
N18A0.0284 (10)0.0371 (11)0.0211 (9)0.0016 (8)−0.0013 (7)−0.0038 (8)
C18B0.0284 (10)0.0371 (11)0.0211 (9)0.0016 (8)−0.0013 (7)−0.0038 (8)
C190.0344 (18)0.0363 (19)0.0381 (19)0.0028 (15)0.0025 (15)0.0013 (15)
C200.0318 (18)0.0329 (19)0.041 (2)−0.0005 (14)0.0037 (15)−0.0014 (15)
I10.03172 (15)0.03684 (16)0.03268 (16)−0.00256 (9)0.00260 (10)−0.00114 (9)
F1A—C11A1.376 (5)C10—C11A1.365 (6)
C1—C21.378 (5)C10—H100.9500
C1—C51.431 (5)C11A—C121.375 (7)
C1—C81.472 (5)C12—C131.378 (7)
C2—N31.328 (5)C12—H120.9500
C2—C151.477 (5)C13—H130.9500
N3—O41.383 (4)C15—C161.383 (5)
N3—C61.444 (6)C15—C201.393 (6)
O4—C51.400 (5)C16—C171.382 (5)
C5—O71.208 (5)C16—H160.9500
C6—H6A0.9800C17—N18A1.336 (6)
C6—H6B0.9800C17—H170.9500
C6—H6C0.9800N18A—C191.334 (5)
C8—C131.392 (6)N18A—H18A0.8800
C8—C91.397 (6)C19—C201.386 (5)
C9—C101.390 (6)C19—H190.9500
C9—H90.9500C20—H200.9500
C2—C1—C5105.4 (3)C10—C11A—C12122.8 (4)
C2—C1—C8129.2 (3)C10—C11A—F1A118.4 (4)
C5—C1—C8125.1 (4)C12—C11A—F1A118.8 (4)
N3—C2—C1111.3 (3)C11A—C12—C13118.5 (4)
N3—C2—C15118.9 (3)C11A—C12—H12120.8
C1—C2—C15129.6 (4)C13—C12—H12120.8
C2—N3—O4108.8 (3)C12—C13—C8121.3 (4)
C2—N3—C6134.4 (4)C12—C13—H13119.4
O4—N3—C6116.8 (3)C8—C13—H13119.4
N3—O4—C5107.6 (3)C16—C15—C20119.5 (3)
O7—C5—O4117.8 (4)C16—C15—C2122.2 (4)
O7—C5—C1135.3 (4)C20—C15—C2118.1 (3)
O4—C5—C1106.9 (3)C17—C16—C15119.1 (4)
N3—C6—H6A109.5C17—C16—H16120.4
N3—C6—H6B109.5C15—C16—H16120.4
H6A—C6—H6B109.5N18A—C17—C16120.5 (4)
N3—C6—H6C109.5N18A—C17—H17119.7
H6A—C6—H6C109.5C16—C17—H17119.7
H6B—C6—H6C109.5C19—N18A—C17121.6 (3)
C13—C8—C9118.2 (4)C19—N18A—H18A119.2
C13—C8—C1120.4 (4)C17—N18A—H18A119.2
C9—C8—C1121.3 (4)N18A—C19—C20120.7 (4)
C10—C9—C8121.1 (4)N18A—C19—H19119.6
C10—C9—H9119.5C20—C19—H19119.6
C8—C9—H9119.5C19—C20—C15118.5 (4)
C11A—C10—C9118.2 (4)C19—C20—H20120.7
C11A—C10—H10120.9C15—C20—H20120.7
C9—C10—H10120.9
C5—C1—C2—N30.7 (5)C1—C8—C9—C10177.6 (4)
C8—C1—C2—N3−173.3 (4)C8—C9—C10—C11A−1.2 (6)
C5—C1—C2—C15−173.3 (4)C9—C10—C11A—C120.7 (7)
C8—C1—C2—C1512.7 (7)C9—C10—C11A—F1A−177.8 (4)
C1—C2—N3—O40.6 (5)C10—C11A—C12—C13−0.1 (7)
C15—C2—N3—O4175.3 (3)F1A—C11A—C12—C13178.4 (4)
C1—C2—N3—C6178.3 (5)C11A—C12—C13—C80.2 (7)
C15—C2—N3—C6−7.0 (8)C9—C8—C13—C12−0.7 (6)
C2—N3—O4—C5−1.7 (5)C1—C8—C13—C12−177.1 (4)
C6—N3—O4—C5−179.9 (4)N3—C2—C15—C1660.6 (5)
N3—O4—C5—O7−178.4 (4)C1—C2—C15—C16−125.8 (5)
N3—O4—C5—C12.1 (4)N3—C2—C15—C20−116.6 (4)
C2—C1—C5—O7178.9 (5)C1—C2—C15—C2057.0 (6)
C8—C1—C5—O7−6.8 (8)C20—C15—C16—C17−1.0 (5)
C2—C1—C5—O4−1.7 (4)C2—C15—C16—C17−178.1 (3)
C8—C1—C5—O4172.6 (3)C15—C16—C17—N18A0.5 (5)
C2—C1—C8—C13−168.6 (4)C16—C17—N18A—C19−0.4 (5)
C5—C1—C8—C1318.5 (6)C17—N18A—C19—C200.7 (6)
C2—C1—C8—C915.1 (6)N18A—C19—C20—C15−1.2 (6)
C5—C1—C8—C9−157.8 (4)C16—C15—C20—C191.4 (6)
C13—C8—C9—C101.3 (6)C2—C15—C20—C19178.6 (4)
  10 in total

1.  An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays.

Authors:  Stefan Laufer; Sabine Thuma; Christian Peifer; Cornelia Greim; Yvonne Herweh; Angela Albrecht; Frank Dehner
Journal:  Anal Biochem       Date:  2005-09-01       Impact factor: 3.365

2.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Substituted isoxazoles as potent inhibitors of p38 MAP kinase.

Authors:  Stefan A Laufer; Simona Margutti; Martina D Fritz
Journal:  ChemMedChem       Date:  2006-02       Impact factor: 3.466

4.  The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.

Authors:  Steven K Laughlin; Michael P Clark; Jane F Djung; Adam Golebiowski; Todd A Brugel; Mark Sabat; Roger G Bookland; Matthew J Laufersweiler; John C VanRens; Jennifer A Townes; Biswanath De; Lily C Hsieh; Susan C Xu; Richard L Walter; Marlene J Mekel; Michael J Janusz
Journal:  Bioorg Med Chem Lett       Date:  2005-05-02       Impact factor: 2.823

5.  SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors.

Authors:  L Revesz; F E Di Padova; T Buhl; R Feifel; H Gram; P Hiestand; U Manning; A G Zimmerlin
Journal:  Bioorg Med Chem Lett       Date:  2000-06-05       Impact factor: 2.823

6.  Potential of p38 inhibitors in the treatment of rheumatoid arthritis.

Authors:  M L Foster; F Halley; J E Souness
Journal:  Drug News Perspect       Date:  2000-10

7.  Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

Authors:  J L Adams; J C Boehm; S Kassis; P D Gorycki; E F Webb; R Hall; M Sorenson; J C Lee; A Ayrton; D E Griswold; T F Gallagher
Journal:  Bioorg Med Chem Lett       Date:  1998-11-17       Impact factor: 2.823

8.  Pyrroles and other heterocycles as inhibitors of p38 kinase.

Authors:  S E de Laszlo; D Visco; L Agarwal; L Chang; J Chin; G Croft; A Forsyth; D Fletcher; B Frantz; C Hacker; W Hanlon; C Harper; M Kostura; B Li; S Luell; M MacCoss; N Mantlo; E A O'Neill; C Orevillo; M Pang; J Parsons; A Rolando; Y Sahly; K Sidler; S J O'Keefe
Journal:  Bioorg Med Chem Lett       Date:  1998-10-06       Impact factor: 2.823

9.  Structural basis of inhibitor selectivity in MAP kinases.

Authors:  Z Wang; B J Canagarajah; J C Boehm; S Kassisà; M H Cobb; P R Young; S Abdel-Meguid; J L Adams; E J Goldsmith
Journal:  Structure       Date:  1998-09-15       Impact factor: 5.006

10.  From imidazoles to pyrimidines: new inhibitors of cytokine release.

Authors:  Stefan A Laufer; Gerd K Wagner
Journal:  J Med Chem       Date:  2002-06-20       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.